NCT00005924View on ClinicalTrials.gov

Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

June 23, 2000

Study Completion Date

February 2, 2010

Conditions
Epstein Barr Virus InfectionHealthy
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00005924 - Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus | Biotech Hunter | Biotech Hunter